z-logo
Premium
Associations between CYP11B2 gene polymorphisms and the response to angiotensin‐converting enzyme inhibitors
Author(s) -
Yu HuiMin,
Lin ShuGuang,
Liu GuoZhang,
Zhang YuQing,
Ma WenJun,
Deng ChunYu
Publication year - 2006
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/j.clpt.2006.02.007
Subject(s) - aldosterone synthase , genotype , blood pressure , medicine , benazepril , angiotensin converting enzyme , endocrinology , aldosterone , polymorphism (computer science) , renin–angiotensin system , biology , gene , genetics
Objective Our objective was to investigate the association between the −344C/T or A6547G polymorphism of the aldosterone synthase gene and the blood pressure response to angiotensin‐converting enzyme inhibitors in a hypertensive cohort. Methods After a 2‐week single‐blind placebo run‐in period, either benazepril or imidapril was administered for 6 weeks to 509 patients with mild to moderate essential hypertension. Polymerase chain reaction combined with restriction enzyme digestion was used to detect the 2 polymorphisms. The achieved changes in systolic and diastolic blood pressure were analyzed for their association with genotypes at the aldosterone synthase gene loci. Results Regarding the −344C/T polymorphism, we observed the CC genotype in 53 patients (10.4%), the CT genotype in 204 (40.1%), and the TT genotype in 252 (49.5%). After 6 weeks of treatment, the reductions in diastolic blood pressure were significantly greater in patients carrying the TT or CT genotype compared with those carrying the CC genotype (9.1 ± 7.0 mm Hg or 8.9 ± 7.0 mm Hg versus 5.1 ± 7.3 mm Hg, respectively; P =.001, ANOVA). Regarding the A6547G polymorphism, we observed the AA genotype in 19 patients (3.7%), the AG genotype in 184 (36.2%), and the GG genotype in 306 (60.1%). There were no significant differences in the blood pressure reductions after treatment among the 3 genotype groups, and there was no interaction between it and the −344C/T polymorphism. Stepwise multiple regression analysis showed that the significant predictors of diastolic blood pressure reduction at 6 weeks were baseline diastolic blood pressure ( P < .001), −344C/T genotype ( P =.007), and sex ( P =.033). Conclusions The −344C/T variant, but not the A6547G variant, of the aldosterone synthase gene may be a determinant of the blood pressure response to angiotensin‐converting enzyme inhibitors in hypertensive patients. Clinical Pharmacology & Therapeutics (2006) 79 , 581–589; doi: 10.1016/j.clpt.2006.02.007

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom